Close search modal

Dr. Noon Fundus

Retina-based AI solution that diagnoses retinal abnormalities

Regulation Info
  • Dr. Noon Fundus_Korea MFDS : [Product Name] DrNoon for fundus screening / [Product License No.] 제허 20-618호 / [Date of Initial Approval] 8 October 2020 / [Validity Period] 8 October 2020 – 30 November 2030 / [Issuer] The Ministry of Food and Drug Safety
  • Dr. Noon Fundus_CE : EC Certificate issued under the European Medical Device Regulation (EU MDD) / [EC Certificate No.] KR21/81826550 / [First Issue Date] 11 May 2021 / [Expiry Date] 31 December 2028 / [Issuer] SGS Belgium NV

AI-powered Solution for
Diagnosing Retinal Abnormalities

Dr. Noon Fundus is a retina-based AI diagnostic software that diagnoses retinal abnormalities.
By analyzing a single retinal photograph, it automatically detects four types of retinal abnormalities: Glaucoma, Media Opacity, Age-related Macular Degeneration, Diabetic Retinopathy, Dr. Noon Fundus assists ophthalmologists, primary care physicians, and screening centers in making
diagnoses related to retinal abnormalities

Retinal Abnormalities Detectable
with Dr. Noon Fundus

  • Glaucoma (Suspect)

    Glaucoma is a disease that damages the optic nerve in the eyes.
    Often known as a silent killer,if left untreated, it will lead to permanent vision loss.

    *Source - National Eye Institute, National Institutes of Health

  • Media Opacity

    A Media Opacity is a clouding of the lens in the eye that affects vision. Most Media Opacity are related to aging and are commonly found among older people.

    *Source - National Eye Institute, National Institutes of Health

  • Age-related Macular Degeneration (AMD)

    Age-related Macular Degeneration (AMD) is an age-related deterioration of the vision focal point in your eye. AMD can interfere with daily activities
    such as driving, reading, and writing.

    *Dr. Noon Fundus screens for age-related macular degeneration and the report flags it as retina normal or abnormal.

    *Source - National Eye Institute, National Institutes of Health

  • Diabetic Retinopathy (DR)

    Diabetic Retinopathy (DR) is a common complication of diabetes leading to severe and permanent blindness. As DR is asymptomatic in the early stages, patients may not notice any change in their vision at first.

    *Dr. Noon Fundus screens for Diabetic Retinopathy (DR) and the report flags it as retina normal or abnormal.

    *Source - National Eye Institute, National Institutes of Health

Patient Journey

Follow the step-by-step journey of a patient visiting the hospital
and see how they meet Dr. Noon Fundus.

  • STEP 1
    Eye Scan

    Take one picture of each eye to capture the retina.

  • STEP 2
    Image Upload

    The retinal images are uploaded to the healthcare institution’s server or cloud platform.

  • STEP 3
    AI Analysis

    Artificial intelligence automatically analyzes suspected retinal abnormalities.

  • STEP 4
    Result Review

    Retinal abnormalities are determined through a promptly delivered report.

Key Benefits

  • High Accuracy

    Based on learning from more than 100,000 retinal images verified by ophthalmology experts, we provide highly reliable diagnoses.

  • Fast Test Results

    The testing procedure is the same as existing retinal exams, and results are also delivered promptly.

  • High Accessibility

    Can be utilized in clinics, hospitals, and health screening centers, providing more patients with the opportunity to receive cardiovascular assessments.

Our Customers

Dr. Noon Fundus is utilized by leading hospitals,
clinics, and check-up centers in Korea and worldwide.

Ready to take the
next step?

Brochure Download